Daiwa Securities Group
AMAG

Daiwa Securities Group’s AMAG Pharmaceuticals AMAG Stock Holding History

Daiwa Securities Group’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-229
Closed -$6K – 1216
2019
Q2 		$6K Buy
+229
New +$2.47K ﹤0.01% 1093

Daiwa Securities Group's AMAG Position: Q4 2020 in Review

Daiwa Securities Group sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 195 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in AMAG in Q1 2018 and held it in 11 quarters. The position peaked at $4K in Q3 2018. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

  • Daiwa Securities Group reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Daiwa Securities Group sold 195 AMAG Pharmaceuticals shares in Q4 2020, an estimated $2K.
  • Daiwa Securities Group first reported a position in AMAG Pharmaceuticals in Q1 2018 and held it in 11 quarters.
  • Daiwa Securities Group's AMAG Pharmaceuticals position peaked at $4K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on Daiwa Securities Group's 13F filing for Q4 2020, filed 4 Feb 2021.